Abcam, ab301263, Human TAB2 knockout A549 cell line

Size: 2 x 1000000Cells / vial / 1000000Cells / vial
TAB2 KO cell line available to order. KO validated by Next Generation Sequencing. Free of charge wild type control available. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.
Key facts
Cell type:A549,
Species or organism:Human,
Tissue:Lung,
Form:LiquidSee storage information,
Knockout validation:Next Generation Sequencing,
Disease:Carcinoma

Product details:
Although we aim to provide customers with a homozygous clone, feasibility will be dependent on the biology of the protein. Should only heterozygous edits be achieved, you will be notified of the outcome and be asked to confirm whether the cell line is acceptable. All clones will be accompanied with DNA sequencing data, and the mutation description.
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-TAB2, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Next Generation Sequencing, Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--196°C, Appropriate long-term storage conditions--196°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
TAB2 also known as TGF-beta-activated kinase 1 binding protein 2 or MAP3K7IP2 is an adapter protein with a mass of approximately 71 kDa. It plays a mechanical role in the nuclear and cytoplasmic compartments acting as a critical component in signaling pathways. Its expression is notable in various tissues including the heart placenta and skeletal muscle. TAB2 mainly functions by interacting with kinases to relay and amplify signals in the cell especially those related to inflammation and stress responses.
Biological function summary
TAB2 maintains a significant position in cellular signaling as part of larger protein complexes. It associates with TAK1 (transforming growth factor-beta-activated kinase 1) to regulate NF-kappaB and MAPK pathways. Through these interactions TAB2 helps cells respond to environmental signals mediating transcriptional responses necessary for adaptation and defense mechanisms. In particular TAB2's role in these complexes underlines its importance in immune response modulation and cellular homeostasis.
Pathways
TAB2 is deeply involved in both the NF-kappaB and MAPK signaling pathways where it cooperates intimately with proteins such as TAK1 and TAB1. These pathways are essential for gene expression regulation in response to pro-inflammatory signals. TAB2 facilitates the activation of IKK complex within the NF-kappaB pathway and JNK in the MAPK pathway. By influencing these pathways TAB2 governs important cellular processes like apoptosis proliferation and differentiation.
TAB2's dysfunction has strong connections with inflammatory and cardiovascular diseases. Its interaction with TAK1 and other proteins can lead to aberrant signaling therefore associating TAB2 with conditions such as rheumatoid arthritis and cardiac hypertrophy. In cardiomyopathies for instance disturbances in TAB2's function can affect signal transduction significantly impacting cardiac muscle structure and function. Understanding TAB2 and its intricate network of protein interactions aids in uncovering therapeutic targets for these diseases.